Nathan E. Wineinger, Ph.D., a research scientist at Scripps Genomic Medicine discusses how mhealth data is moving towards big data at a rapid pace at the recent [email protected] workshop last month.
Mobile health (mHealth) technologies allow for the generation of intensive care unit medical information, literally, in the palm of your hand. A smart phone can be transformed into a mobile heart monitor to diagnose atrial fibrillation, and continuous glucose monitoring has revolutionized the way diabetics manage their blood sugar levels. The digitization of human health through noninvasive devices and sensors can provide meaningful measures of individual wellness outside of a clinical environment.
This information can then be used to guide health decisions — or personalize medicine. However, mHealth data presents a computational challenge as it can be both wide and long (i.e. big data). Furthermore, this challenge can be broken into two components that are both vital to the production of actionable health care: data storage and processing; and its interpretation. It is this latter component that is notoriously omitted in the conversation on big data.
This talk lead by research scientist at
, Nathan E. Wineinger, Ph.D. will focus on analytical methods designed to interpret information from big data sources. Particularly, this talk will address approaches to analyze data on numerous variables from multiple sources which are serially correlated over time.
This investigation is motivated by a recent mHealth study conducted at the
designed to assess the relationship between neurocognitive and cardiovascular/pulmonary measurements, and the overall health benefits of meditation.
About Nathan Wineinger, Ph.D.
Nathan E. Wineinger, Ph.D., is a research scientist at Scripps Genomic Medicine within Scripps Health. He joined STSI in the fall of 2011.
His expertise is in statistical approaches to human genetics and genomics research – particularly in the application and development of quantitative methods for identifying the etiology of common, complex disease.
Nathan’s interests include multi-locus and whole-genome statistical methods to predict complex disease, imputation, and copy number variation. Recently, he has applied these approaches to obesity and insulin resistance, echocardiographic traits, longevity, neuroimaging, and pharmacogenetics.
Fred Pennic is the founder of HIT Consultant. Fred has significant experience as a management consultant working with healthcare providers across the country. As a digital media strategist, Fred assists healthcare technology companies in improving the ROI of their brand visibility/awareness, content marketing strategies, and digital/social media campaigns.
Is mHealth Data Moving Towards Big Data? – December 10, 2013
3 Big Predictions for the Global Healthcare Market in 2014 – December 9, 2013
7 Security Trends Healthcare Organizations Will Confront in 2014 – December 6, 2013
Jump to original: